T. Rowe Price holds 11.7% of Shattuck Labs
T. Rowe Price Investment Management, Inc. has filed a Schedule 13G reporting beneficial ownership of 7,373,891 shares of Shattuck Labs Inc common stock, representing 11.7% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
T. Rowe Price Investment Management, Inc. has filed a Schedule 13G reporting beneficial ownership of 7,373,891 shares of Shattuck Labs Inc common stock, representing 11.7% of the class.
The firm reports sole voting and sole dispositive power over all reported shares and certifies that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Shattuck Labs.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Shattuck Labs (STTK) does T. Rowe Price report on this Schedule 13G?
Is T. Rowe Price’s Shattuck Labs (STTK) position considered passive or for control purposes?
Who is the reporting person on the Shattuck Labs (STTK) Schedule 13G and where is it based?
What type of securities in Shattuck Labs (STTK) does this Schedule 13G cover?
AI-generated analysis. How Rhea-AI works. Not financial advice.